Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Planning finances for a growing family requires careful consideration. Learn expert tips to manage your budget effectively during this transition.
13,157 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
KB Home's Q1 2026 results shed light on the company’s earnings trajectory and the housing market dynamics. This guide...
Avis Budget Group stock surged this week as travel demand picked up and airport bottlenecks nudged customers toward r...
A new ETF focused on CTAs began trading this week, giving U.S. investors direct exposure to trend-following across mu...
Target’s dividend king status remains intact for now, but a cash flow squeeze and higher capex raise questions for in...
As 2026 unfolds, investors eye the best blockchain penny stocks for upside amid renewed crypto infrastructure gains. ...
AST SpaceMobile and Rocket Lab fell roughly 4% intraday, then clawed back losses as markets rotated amid a volatile w...
U.S. consumer discretionary stocks rise as demand improves in March 2026. Analysts cite pricing power and resilient c...
Mortgage rates jump 6.5% this spring, reshaping affordability for buyers. As lenders adjust, borrowers weigh higher p...
The Federal Reserve is anticipated to keep the federal funds rate unchanged as Powell nears the end of his chair tenu...
The YieldMax PYPL Option Income Strategy ETF is under pressure as its strategy to harvest option premiums collides wi...
BMO Capital Markets cuts Lithium Americas' price target to $4.50, citing 15% capex inflation at Thacker Pass and ongo...